Genetic variants regulate NR1H3 expression and contribute to multiple sclerosis risk

Area of Science:

• Genetics
• Neuroimmunology
• Genomics

Background:

• Previous research yielded negative results on the association between specific NR1H3 genetic variants and multiple sclerosis (MS) risk.
• Replication studies are crucial for validating initial findings and ensuring accurate interpretation of genetic associations.

Purpose of the Study:

• To re-evaluate the association between five NR1H3 genetic variants (rs11039149, rs12221497, rs2279238, rs7120118, rs7114704) and MS risk.
• To investigate the regulatory role of these variants on NR1H3 gene expression.

Main Methods:

• Utilized large-scale genome-wide association studies (GWAS) encompassing 9772 MS cases and 17,376 controls.
• Integrated expression quantitative trait loci (eQTL) datasets to assess gene expression regulation.

Main Results:

• Identified significant associations between two NR1H3 variants (rs7120118 and rs2279238) and MS risk.
• Demonstrated that these significant variants can substantially regulate NR1H3 expression across various human tissues and cells.

Conclusions:

• The findings provide critical supplementary evidence supporting the association between specific NR1H3 variants and MS susceptibility.
• These results highlight the importance of robust replication studies in genetic association research for complex diseases like MS.